Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market - Reuters

Reuters | July 12, 2024, 6 p.m. | Original
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market Reuters
Lundin Mining, BHP weighing joint bid for copper miner Filo Corp, sources say - Reuters Wall Street closes higher on bets for Fed rate cut - Reuters